Search

everythinglearnresearchcommunity

for

Search:↓

Normal levels of DHT can reduce belly fat and increase muscle, but too much can lead to hair loss, prostate issues, and possibly heart disease.

Almost all patients with chronic kidney disease not yet on dialysis have at least one skin problem.

Certain MC4R gene variants are linked to higher BMI in obese women with PCOS but do not cause PCOS.

Polycystic ovary syndrome is found in 6.5% of unselected Caucasian women in Spain.

About 6.5% of young Caucasian women in Spain have polycystic ovary syndrome.

Women with Polycystic Ovary Syndrome (PCOS) have a lower health-related quality of life, especially those with an anovulatory phenotype, and may need specific interventions to improve it.

The severity of symptoms in nonclassical congenital adrenal hyperplasia is not determined by CYP21A2 gene variations.

Androgenetic alopecia is not linked to higher risks of hypertension or hyperaldosteronism.

Women with PCOS have worse physical health but similar mental health compared to those without PCOS.

Satoyoshi syndrome is likely an autoimmune disease that mainly affects young women and improves with immune-related treatments.

Skin problems like excessive hair growth, acne, and dark skin patches can be signs of Polycystic Ovarian Disease, which may also be linked to family history and a risk for diabetes.

Levetiracetam often causes behavioral issues, while oxcarbazepine is more likely to cause sleepiness in epilepsy patients.

Girls with PCOS have higher levels of certain androgens, which are linked to excess hair growth, but these androgens don't help diagnose PCOS.

People with alopecia areata have higher rates of mental health issues, autoimmune diseases, and infections.

Women with hair loss have higher heart disease risk and unhealthy cholesterol levels.

Androgenetic alopecia is a genetic hair loss condition, more severe in men, and can also be caused by hormonal imbalances in women.

Bimatoprost ophthalmic solution 0.03% safely and effectively increases eyelash growth when applied to the upper eyelid.

Women with PCOS in North China often have hirsutism and acne, with hirsutism linked to metabolic issues.

Women with PCOS may take longer to get pregnant but can have a normal family size, and should manage their overall health to reduce long-term health risks.

Women with PCOS often feel stigmatized and have mood issues, which can lower their sexual satisfaction, but proper treatment and support can help.

Human sebaceous glands contain enzymes that affect androgen production and may influence sebum production and acne.

Hormonal changes and psychological issues can cause sexual dysfunction in postmenopausal women. Behavioral therapy is recommended first, with hormone replacement helping some symptoms but not libido. Testosterone can improve libido, but its effects on overall sexual function are unclear. Emotional and relationship issues should be addressed before using medication, and the benefits and risks of testosterone supplementation should be considered.

A simple screening method found that 6.3% of women in a semiurban area in Sri Lanka have polycystic ovary syndrome, with most showing menstrual irregularities.

Dogs with generalized discoid lupus erythematosus have similar symptoms to humans and need continuous treatment.

Busulfan/cyclophosphamide and total bone irradiation are equally effective for AML transplants.

Women with polycystic ovary syndrome tend to have a longer distance between the clitoris and anus.

Low and ultralow doses of flutamide can cause liver damage in young women with high androgen levels, regardless of dose or birth control use, with higher risk for those with higher BMI and liver enzyme levels before treatment.

Women with PCOS have a higher risk of diabetes, heart problems, certain cancers, and mental health issues, but early treatment can help manage these risks.

Women with PCOS are more likely to have insulin resistance and obesity, especially those with the most severe type I PCOS.

Alopecia areata needs more recognition and better treatment access in Latin America to improve patient care and outcomes.